Posted by Michael Wonder on 11 Jun 2017
The FDA either will find its voice, or get its comeuppance, under Commissioner Gottlieb
10 June 2017 - Dr. Scott Gottlieb, the new Commissioner of the FDA, has a big job and a lot of opinions.
To say that Gottlieb has been outspoken in his criticism of the agency is a dramatic understatement. Indeed, he has written literally scores of columns and policy papers that, in tone and substance, fall somewhere between severe criticism and outright excoriation of FDA policy and practice.
As he settles in and announces new policies designed to stem opiate abuse and foster generic competition, it will be fascinating to see how his tenure plays out. This could portend great changes, or it could turn out to be another edition of the familiar Washington parlor game . . . “Let’s see if the interloping change agent can tame the entrenched bureaucracy?”
